The Turkish Treasury has extended an external borrowing authorisation without a Treasury guarantee to the Izmir Municipality for a one-year period, the municipality said on March 8.
Izmir is in talks to obtain foreign loans to finance a €1bn metro line project, while it has already agreed loans worth €490mn for the investment, it also said.
As of end-Q3 2020, the municipality held $492mn of external debt stock not covered by a Treasury guarantee, while its Izsu (Izmir Water and Sewerage Administration) held another $28mn.
The municipality also held $81mn of Treasury-guaranteed foreign debt at end-September.
Izmir has a Fitch Ratings BB-/Stable rating, three notches below investment grade and in line with Turkey’s sovereign rating. It also has a B2/Negative, five notches below investment grade in line with Turkey’s sovereign rating, from Moody’s Investors Service.
Related Articles
Russia’s second biggest bank VTB reports strong 15.4% rise in 1Q25 net profit
Russia’s second-largest lender, VTB, reported a 15.4% year-on-year increase in net profit for the first quarter of 2025, to RUB141.2bn ($1.70bn), despite a sharp decline in net interest margin ... more
Kuwait sovereign fund sues over London skyscraper that threatens light access
Kuwait's sovereign wealth fund has initiated legal action against one of the City of London's largest development projects, claiming the planned 36-storey tower will obstruct light to a building it ... more
Russian state VTB Bank to divest non-core assets
Russia’s second-largest bank state-controlled VTB plans to divest non-core assets unrelated to banking operations within the next five years, according to Interfax citing the bank's CEO, ... more
Most Read
-
Kremlin demands sanctions relief in temporary Ukraine conflict ceasefire deal
1 month ago
-
Russian region bribes schoolgirls to get pregnant
1 month ago
-
No country has agreed to resettle Palestinians, says acting Israeli envoy to Russia
1 month ago
-
Who will be Serbia’s next prime minister?
1 month ago
-
Serbian biotech Dren Bio sold to Sanofi for $1.9bn
1 month ago